Enlivex Therapeutics
ENLV
ENLV
26 hedge funds and large institutions have $3.08M invested in Enlivex Therapeutics in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
7
Closed
2
Calls
$45K
Puts
$7K
Net Calls
+$38K
Net Calls Change
+$34K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$68K |
| 2 |
Jane Street
New York
|
+$65.9K |
| 3 |
Millennium Management
New York
|
+$34.1K |
| 4 |
Renaissance Technologies
New York
|
+$21.6K |
| 5 |
VF
Virtu Financial
New York
|
+$17K |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$413K |
| 2 |
Morgan Stanley
New York
|
-$37.8K |
| 3 |
AWAG
ARS Wealth Advisors Group
St. Petersburg,
Florida
|
-$11.7K |
| 4 |
HF
HRT Financial
New York
|
-$5.93K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$2.17K |
